http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6038396-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb4ee28d43b5e8d4a3c5141fa9bcfeb0
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-067
filingDate 1983-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf1d827e8c8b0b63559643e4eefd000b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_059ff566cecae01da5f02778ab95def5
publicationDate 1985-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S6038396-A
titleOfInvention Preparation of 5-fluorocytidine compound
abstract PURPOSE: To obtain the titled compound useful as a carcinostatic agent and antiviral agent in high yield efficiently, by reacting a cytidine compound with fluorinating agent in a mixed solvent containing hydrogen fluoride and a carboxylic acid, etc. to give an intermediate, reacting it with ammonia, etc. n CONSTITUTION: A cytidine compound shown by the formula I (R 1 WR 4 are H, or lower acyl) is reacted with a fluorinating agent (e.g., F 2 , CF 3 OF, etc., usually diluted in an inert gas such as N 2 to 50mol% and used) in a mixed solvent of (A) hydrogen fluoride and (B) a carboxylic acid shown by the formula R 5 OH [R 5 is (halogenated)lower acyl, or halogenated lower alkyl] or a halogenated alcohol (preferably acetic acid, or trifluoroacetic acid) (preferably 5W80wt% component A, ≤500ppm water content) to give a 5-fluorocytidine intermediate shown by the formula II. This compound is reacted with ammonia or an amine, to give the desired compound by the formula III. n COPYRIGHT: (C)1985,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7365188-B2
priorityDate 1983-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226563453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415822905
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122948
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16861
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12310447
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544063
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6175
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522894
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398598
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6422
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14917
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398597
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419574560
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID78989
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457280313

Total number of triples: 33.